77 related articles for article (PubMed ID: 28468043)
1. [Prognostic significance of Cripto-1 in cervical squamous carcinoma].
Xu QQ; Ren CC; Yang L; Ban ZY; Liu L; Lu JH; Yu YX
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):338-339. PubMed ID: 28468043
[No Abstract] [Full Text] [Related]
2. Hepatoma-derived growth factor is a novel prognostic factor for cervical squamous cell carcinoma.
Ye F; Cheng Q; Zhou C; Ma J; Chen H
Histopathology; 2011 May; 58(6):982-4. PubMed ID: 21585431
[No Abstract] [Full Text] [Related]
3. The Function and Prognostic Significance of Cripto-1 in Colorectal Cancer.
Sato J; Karasawa H; Suzuki T; Nakayama S; Katagiri M; Maeda S; Ohnuma S; Motoi F; Naitoh T; Unno M
Cancer Invest; 2020 Apr; 38(4):214-227. PubMed ID: 32157913
[TBL] [Abstract][Full Text] [Related]
4. Cripto stabilizes GRP78 on the cell membrane.
Kouznetsova VL; Hu H; Teigen K; Zanetti M; Tsigelny IF
Protein Sci; 2018 Mar; 27(3):653-661. PubMed ID: 29226519
[TBL] [Abstract][Full Text] [Related]
5. Cripto-1 localizes to dynamic and shed filopodia associated with cellular migration in glioblastoma cells.
Gudbergsson JM; Duroux M
Eur J Cell Biol; 2019 Dec; 98(5-8):151044. PubMed ID: 31543278
[TBL] [Abstract][Full Text] [Related]
6. Cripto-1 is overexpressed in carcinoma ex pleomorphic adenoma of salivary gland.
Silva LP; da Silva LAB; Sedassari BT; de Sousa SCOM; Dos Santos Pereira J; de Souza LB; da Costa Miguel MC
Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1595-1600. PubMed ID: 29594385
[TBL] [Abstract][Full Text] [Related]
7. [Expression of SFRP4 and DKK1 in cervical squamous cell carcinoma and the clinicopathological implications].
Li X; Hou A; Li Z; Fang S; Zhang Y; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):1063-7. PubMed ID: 26198963
[TBL] [Abstract][Full Text] [Related]
8. CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
Zoni E; Chen L; Karkampouna S; Granchi Z; Verhoef EI; La Manna F; Kelber J; Pelger RCM; Henry MD; Snaar-Jagalska E; van Leenders GJLH; Beimers L; Kloen P; Gray PC; van der Pluijm G; Kruithof-de Julio M
Oncogene; 2017 Aug; 36(33):4739-4749. PubMed ID: 28394345
[TBL] [Abstract][Full Text] [Related]
9. Cripto-1 promotes resistance to drug-induced apoptosis by activating the TAK-1/NF-κB/survivin signaling pathway.
Zhang Y; Mi X; Song Z; Li Y; YingShi ; Niu J
Biomed Pharmacother; 2018 Aug; 104():729-737. PubMed ID: 29807222
[TBL] [Abstract][Full Text] [Related]
10. An evolving web of signaling networks regulated by Cripto-1.
Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
[TBL] [Abstract][Full Text] [Related]
11. The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells.
Park SW; Do HJ; Han MH; Choi W; Kim JH
FEBS Lett; 2018 Jan; 592(1):24-35. PubMed ID: 29223130
[TBL] [Abstract][Full Text] [Related]
12. Cripto-1 modulates macrophage cytokine secretion and phagocytic activity via NF-κB signaling.
Zhang DM; Bao YL; Yu CL; Wang YM; Song ZB
Immunol Res; 2016 Feb; 64(1):104-14. PubMed ID: 26476731
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
Miharada K; Karlsson G; Rehn M; Rörby E; Siva K; Cammenga J; Karlsson S
Ann N Y Acad Sci; 2012 Aug; 1266():55-62. PubMed ID: 22901256
[TBL] [Abstract][Full Text] [Related]
14. CD109 expression is increased in cutaneous squamous cell carcinoma.
Dong F; Wang Y; Li L; Wang Y; Liu X; Liu J
J Dermatol; 2014 Oct; 41(10):947-9. PubMed ID: 25271095
[No Abstract] [Full Text] [Related]
15. Cripto-1: an extracellular protein - connecting the sequestered biological dots.
Klauzinska M; Bertolette D; Tippireddy S; Strizzi L; Gray PC; Gonzales M; Duroux M; Ruvo M; Wechselberger C; Castro NP; Rangel MC; Focà A; Sandomenico A; Hendrix MJ; Salomon D; Cuttitta F
Connect Tissue Res; 2015; 56(5):364-80. PubMed ID: 26327334
[TBL] [Abstract][Full Text] [Related]
16. GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer.
Lee HY; Jung JH; Cho HM; Kim SH; Lee KM; Kim HJ; Lee JH; Shim BY
Cancer Res Treat; 2015 Oct; 47(4):804-12. PubMed ID: 25687871
[TBL] [Abstract][Full Text] [Related]
17. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
[TBL] [Abstract][Full Text] [Related]
18. Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway.
Shi Y; Bao YL; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
J Biomol Screen; 2011 Jun; 16(5):525-35. PubMed ID: 21378277
[TBL] [Abstract][Full Text] [Related]
19. An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours.
Kelly RK; Olson DL; Sun Y; Wen D; Wortham KA; Antognetti G; Cheung AE; Orozco OE; Yang L; Bailly V; Sanicola M
Eur J Cancer; 2011 Jul; 47(11):1736-46. PubMed ID: 21458984
[TBL] [Abstract][Full Text] [Related]
20. Nodal/Cripto signaling in fetal male germ cell development: implications for testicular germ cell tumors.
Spiller CM; Bowles J; Koopman P
Int J Dev Biol; 2013; 57(2-4):211-9. PubMed ID: 23784832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
